水解磷酸脂誘導人類內皮細胞黏著因子ICAM-1與趨化因子IL-8, MCP-1表達之研究

Enhancement Effects of Lysophospholipids on ICAM-1, IL-8 and MCP-1 Expression on Human Endothelial Cell

林紀佑(Chi-Iou Lin)

指導教授 ： 李心予

國立臺灣大學/生命科學院/動物學研究研究所/碩士(2004年)

https://doi.org/10.6342/NTU.2004.01685

摘要

水解磷酸脂 Lysophosphotidic Acid (LPA)與 Sphingosine 1-Phsophate (S1P)均為存在於人體血液循環中低分子量之脂肪酸，透過辨識與連結細胞膜上Edg族受器進而調控影響細胞的生理活性，包括刺激血管內皮細胞之複製及移行。本項實驗的研究目的在探討水解磷酸脂在人類內皮細胞中對於細胞黏著因子ICAM-1與趨化因子IL-8和MCP-1表現的影響。
在human umbilical cord vein endothelial cells(HUVECs)中，透過LPA與S1P的處理均能夠誘導ICAM-1的mRNA與蛋白質的表現，並且觀察到了時間與劑量依賴的現象。透過細胞流噬儀與西方墨點的分析，LPA與S1P刺激內皮細胞表現ICAM-1蛋白質的表現於8小時後達到最大量。更進一步的，利用前處理pertussis toxin ，Gi的專一性抑制劑及PDTC，NF-

關鍵字

內皮細胞 ； 水解磷酸脂

並列摘要

Lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) are both low molecular weight lysophospholipid (LPL) ligands which are recognized by the Edg family of G protein-coupled receptors. In endothelial cells, these two ligands activate Edg receptors resulting in cell proliferation and cell migration. We examined the impact of lyosophosphlipids on the expression of intercellular adhesion molecule-1 (ICAM-1), and on the production of interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1), key regulators of leukocyte recruitment in human umbilical cord vein endothelial cells (HUVECs). Incubation with both LPA and S1P enhanced ICAM-1 mRNA and protein expressions in HUVECs were in a dose- and time-dependent manner. Maximal expression appeared at 8 h postligand treatment, as detected by flow cytometry and Western blotting. Furthermore, prior treatment of HUVECs with pertussis toxin, a specific inhibitor of Gi, or PDTC, an inhibitor of the NFκB pathway, prevented the enhanced effect of LPA- and S1P-induced ICAM-1 expression. However, pretreatment of HUVECs with exoC3, an inhibitor of rho, had no effect on LPL-enhanced ICAM-1 expression. In a static cell-cell adhesion assay system, pretreatment of LPL enhanced the adhesion between HUVECs and U937 cells, a human mononucleated cell line. The enhanced adhesion effect could be prevented by preincubation with a functional blocking antibody against human ICAM-1. On the other hand, LPA and S1P enhanced IL-8 and MCP-1 mRNA expression and protein secretion in a dose- and time-dependent fashion. Maximal mRNA expression appeared at 16 h postligand treatment. By chemical inhibitors prior treatment, we found both LPA and S1P enhanced IL-8 and MCP-1 expression through a Gi-, rho- and NF

並列關鍵字

endothelial cell ； lysophopholipids

參考文獻

An, S., Goetzl, E.J., Lee, H. (1998) Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. J Cell Biochem 30-31(Suppl):147-57.

Baggiolini, M., Dewald, B., and Moser, B. (1997) Human chemokines: an update. Annu Rev Immunol 15: 675-705.

Balazs, L., Okolicany, J., Ferrebee, M., Tolley, B., Tigyi, G. (2001) Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo. Am J Physiol Regul Integr Comp Physiol 280: R466-72.

Bayless K.J. and Davis G.E. (2003) Sphingosine-1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in three-dimensional collagen and fibrin matrices. Biochem. Biophys. Res. Commun 312:903-13.

Ben-Baruch, A., Xu, L., Young, P.R., Bengali, K., Oppenheim, J.J., Wang, M.J. (1995) Monocyte chemoattractant protein-3 (MCP3) interacts with multiple leukocyte receptors: C-C CKR1, a receptor for macrophage inflammatory protein 1a/RANTES, is also a functional receptor for MCP3. J Biol Chem 270:22123-8.